Literature DB >> 19994872

Efficient synthesis of pyrimido[1,2-c] [1,3]benzothiazin-6-imines and related tricyclic heterocycles by S(N)Ar-type C-S, C-N, or C-O bond formation with heterocumulenes.

Tsukasa Mizuhara1, Shinya Oishi, Nobutaka Fujii, Hiroaki Ohno.   

Abstract

A simple and practical synthetic method of pyrimido[1,2-c][1,3]benzothiazin-6-imines and related tricyclic heterocycles has been developed. Treatment of 2-(2-haloaryl)tetrahydropyrimidines with NaH and a heterocumulene such as carbon disulfide, isothiocyanates, and isocyanates in DMF provides the desired cyclization products through a regioselective S(N)Ar-type reaction. This method provides direct access to PD 404182 and related compounds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19994872     DOI: 10.1021/jo902327n

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.

Authors:  Ana M Chamoun-Emanuelli; Michael Bobardt; Bernard Moncla; Marie K Mankowski; Roger G Ptak; Philippe Gallay; Zhilei Chen
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

2.  A novel and potent inhibitor of dimethylarginine dimethylaminohydrolase: a modulator of cardiovascular nitric oxide.

Authors:  Yohannes T Ghebremariam; Daniel A Erlanson; John P Cooke
Journal:  J Pharmacol Exp Ther       Date:  2013-10-17       Impact factor: 4.030

3.  Hypervalent iodine(III)-induced methylene acetoxylation of 3-oxo-N-substituted butanamides.

Authors:  Wei-Bing Liu; Cui Chen; Qing Zhang; Zhi-Bo Zhu
Journal:  Beilstein J Org Chem       Date:  2011-10-19       Impact factor: 2.883

4.  CuI nanoparticle-catalyzed synthesis of tetracyclic benzo[e]benzo[4,5]imidazo[1,2-c][1,3]thiazin-6-imine heterocycles by SNAr-type C-S, C-N bond formation from isothiocyanatobenzenes and benzimidazoles.

Authors:  Xiaolong Guo; Luyao Wang; Jing Hu; Mengmeng Zhang
Journal:  RSC Adv       Date:  2018-06-19       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.